Genome-wide Identification of Murine Interferon Genes in Microglial-mediated Neuroinflammation in Alzheimer's Disease
Overview
Authors
Affiliations
Interferons play a major role in microglial-mediated neuroinflammation in Alzheimer's disease (AD). We investigated the interferon transcriptome (AD versus non-AD) using N9 and murine microglia. We identified 64 interferon-related differentially expressed genes (DEG) in LPS-stimulated N9 microglia versus control cells, 26 DEG in microglia from 5XFAD versus wild-type mice, with 13 DEG common to both datasets. Network analyses identified potential key mediators (Cxcl10, Ifit3) of the interferon response in AD. Gene-drug interaction analysis identified therapeutics targeting interferon-related genes. These data characterize the microglial interferon response in AD, providing new targets and therapeutics directed towards interferon-related neuroinflammation in AD.
Toledano A, Rodriguez-Casado A, Alvarez M, Toledano-Diaz A Brain Sci. 2024; 14(11).
PMID: 39595866 PMC: 11591712. DOI: 10.3390/brainsci14111101.
Ketone body metabolism and the NLRP3 inflammasome in Alzheimer's disease.
Shippy D, Evered A, Ulland T Immunol Rev. 2024; 329(1):e13365.
PMID: 38989642 PMC: 11724017. DOI: 10.1111/imr.13365.
Mitigation of CXCL10 secretion by metabolic disorder drugs in microglial-mediated neuroinflammation.
Oliai S, Shippy D, Ulland T J Neuroimmunol. 2024; 391:578364.
PMID: 38718558 PMC: 11165694. DOI: 10.1016/j.jneuroim.2024.578364.
Hong S, Kim J, Ahn M, Jung K, Moon C, Ahn C Mol Neurobiol. 2024; 61(8):5771-5786.
PMID: 38233686 DOI: 10.1007/s12035-024-03923-0.